Global Biolayer Interferometry (BLI) Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI07241227

Publication Date:

July 29, 2024

Pages:

117

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

Biolayer Interferometry (BLI) is a label-free optical technique for measuring biomolecular interactions in real-time. It analyzes the interference pattern of white light reflected from an immobilized protein layer on the biosensor tip and an internal reference layer. Only molecules binding to or dissociating from the biosensor can shift the interference pattern, making BLI unique and ideal for protein binding, quantitation, affinity, and kinetics in crude samples. Bio-Layer Interferometry measures biomolecular interactions by analyzing interference patterns of white light reflected from the surface of a biosensor tip. In BLI experiment, one molecule is immobilized to a biosensor and binding to a second molecule is measured. The molecules that bind or dissociate themselves from the biosensor causes a shift in the interference pattern that is measured in real-time. The unbound molecules, variations in the refractive index of the surrounding medium or flow rate, however, do not affect the interference. This unique feature of BLI technology therefore allows measuring crude samples to determine the kinetics and affinity of molecular interactions. Anotheradvantage of BLI is that the number of sensors can be scaled up easily without making the system more error-prone or complex. Theoretically, there is no need to regenerate single sensors, because immobilizing an equal amount of ligand on additional sensors can easily create duplicates of the surface.
The global Biolayer Interferometry (BLI) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淏iolayer Interferometry (BLI) Industry Forecast鈥� looks at past sales and reviews total world Biolayer Interferometry (BLI) sales in 2022, providing a comprehensive analysis by region and market sector of projected Biolayer Interferometry (BLI) sales for 2023 through 2029. With Biolayer Interferometry (BLI) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biolayer Interferometry (BLI) industry.
This Insight Report provides a comprehensive analysis of the global Biolayer Interferometry (BLI) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biolayer Interferometry (BLI) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Biolayer Interferometry (BLI) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biolayer Interferometry (BLI) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biolayer Interferometry (BLI).
United States market for Biolayer Interferometry (BLI) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Biolayer Interferometry (BLI) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Biolayer Interferometry (BLI) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Biolayer Interferometry (BLI) players cover Ichor Life Sciences, Inc, Creative BioMart, GenScript, ROCKLAND IMMUNOCHEMICALS, INC, BPS Bioscience, Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Biolayer Interferometry (BLI) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Affinity and Kinetic Analysis
Drug and Antibody Screening
Drug and Antibody Discovery
Protein Quantification
Others
Segmentation by Application:
Pharmaceutical Industry
Diagnostics
Biotechnology
Scientific Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Affinity and Kinetic Analysis
Drug and Antibody Screening
Drug and Antibody Discovery
Protein Quantification
Others
Segmentation by Application:
Pharmaceutical Industry
Diagnostics
Biotechnology
Scientific Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ichor Life Sciences, Inc
Creative BioMart
GenScript
ROCKLAND IMMUNOCHEMICALS, INC
BPS Bioscience, Inc
Creative Proteomics
Creative Biostructure
Profacgen
Creative Biolabs
Biocult
KMD Bioscience Co., Ltd

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biolayer Interferometry (BLI) Market Size 2019-2030
2.1.2 Biolayer Interferometry (BLI) Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Biolayer Interferometry (BLI) by Country/Region, 2019, 2023 & 2030
2.2 Biolayer Interferometry (BLI) Segment by Type
2.2.1 Affinity and Kinetic Analysis
2.2.2 Drug and Antibody Screening
2.2.3 Drug and Antibody Discovery
2.2.4 Protein Quantification
2.2.5 Others
2.3 Biolayer Interferometry (BLI) Market Size by Type
2.3.1 Biolayer Interferometry (BLI) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biolayer Interferometry (BLI) Market Size Market Share by Type (2019-2024)
2.4 Biolayer Interferometry (BLI) Segment by Application
2.4.1 Pharmaceutical Industry
2.4.2 Diagnostics
2.4.3 Biotechnology
2.4.4 Scientific Research
2.4.5 Others
2.5 Biolayer Interferometry (BLI) Market Size by Application
2.5.1 Biolayer Interferometry (BLI) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biolayer Interferometry (BLI) Market Size Market Share by Application (2019-2024)
3 Biolayer Interferometry (BLI) Market Size by Player
3.1 Biolayer Interferometry (BLI) Market Size Market Share by Player
3.1.1 Global Biolayer Interferometry (BLI) Revenue by Player (2019-2024)
3.1.2 Global Biolayer Interferometry (BLI) Revenue Market Share by Player (2019-2024)
3.2 Global Biolayer Interferometry (BLI) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biolayer Interferometry (BLI) by Region
4.1 Biolayer Interferometry (BLI) Market Size by Region (2019-2024)
4.2 Global Biolayer Interferometry (BLI) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Biolayer Interferometry (BLI) Market Size Growth (2019-2024)
4.4 APAC Biolayer Interferometry (BLI) Market Size Growth (2019-2024)
4.5 Europe Biolayer Interferometry (BLI) Market Size Growth (2019-2024)
4.6 Middle East & Africa Biolayer Interferometry (BLI) Market Size Growth (2019-2024)
5 Americas
5.1 Americas Biolayer Interferometry (BLI) Market Size by Country (2019-2024)
5.2 Americas Biolayer Interferometry (BLI) Market Size by Type (2019-2024)
5.3 Americas Biolayer Interferometry (BLI) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biolayer Interferometry (BLI) Market Size by Region (2019-2024)
6.2 APAC Biolayer Interferometry (BLI) Market Size by Type (2019-2024)
6.3 APAC Biolayer Interferometry (BLI) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biolayer Interferometry (BLI) Market Size by Country (2019-2024)
7.2 Europe Biolayer Interferometry (BLI) Market Size by Type (2019-2024)
7.3 Europe Biolayer Interferometry (BLI) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biolayer Interferometry (BLI) by Region (2019-2024)
8.2 Middle East & Africa Biolayer Interferometry (BLI) Market Size by Type (2019-2024)
8.3 Middle East & Africa Biolayer Interferometry (BLI) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biolayer Interferometry (BLI) Market Forecast
10.1 Global Biolayer Interferometry (BLI) Forecast by Region (2025-2030)
10.1.1 Global Biolayer Interferometry (BLI) Forecast by Region (2025-2030)
10.1.2 Americas Biolayer Interferometry (BLI) Forecast
10.1.3 APAC Biolayer Interferometry (BLI) Forecast
10.1.4 Europe Biolayer Interferometry (BLI) Forecast
10.1.5 Middle East & Africa Biolayer Interferometry (BLI) Forecast
10.2 Americas Biolayer Interferometry (BLI) Forecast by Country (2025-2030)
10.2.1 United States Market Biolayer Interferometry (BLI) Forecast
10.2.2 Canada Market Biolayer Interferometry (BLI) Forecast
10.2.3 Mexico Market Biolayer Interferometry (BLI) Forecast
10.2.4 Brazil Market Biolayer Interferometry (BLI) Forecast
10.3 APAC Biolayer Interferometry (BLI) Forecast by Region (2025-2030)
10.3.1 China Biolayer Interferometry (BLI) Market Forecast
10.3.2 Japan Market Biolayer Interferometry (BLI) Forecast
10.3.3 Korea Market Biolayer Interferometry (BLI) Forecast
10.3.4 Southeast Asia Market Biolayer Interferometry (BLI) Forecast
10.3.5 India Market Biolayer Interferometry (BLI) Forecast
10.3.6 Australia Market Biolayer Interferometry (BLI) Forecast
10.4 Europe Biolayer Interferometry (BLI) Forecast by Country (2025-2030)
10.4.1 Germany Market Biolayer Interferometry (BLI) Forecast
10.4.2 France Market Biolayer Interferometry (BLI) Forecast
10.4.3 UK Market Biolayer Interferometry (BLI) Forecast
10.4.4 Italy Market Biolayer Interferometry (BLI) Forecast
10.4.5 Russia Market Biolayer Interferometry (BLI) Forecast
10.5 Middle East & Africa Biolayer Interferometry (BLI) Forecast by Region (2025-2030)
10.5.1 Egypt Market Biolayer Interferometry (BLI) Forecast
10.5.2 South Africa Market Biolayer Interferometry (BLI) Forecast
10.5.3 Israel Market Biolayer Interferometry (BLI) Forecast
10.5.4 Turkey Market Biolayer Interferometry (BLI) Forecast
10.6 Global Biolayer Interferometry (BLI) Forecast by Type (2025-2030)
10.7 Global Biolayer Interferometry (BLI) Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Biolayer Interferometry (BLI) Forecast
11 Key Players Analysis
11.1 Ichor Life Sciences, Inc
11.1.1 Ichor Life Sciences, Inc Company Information
11.1.2 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Product Offered
11.1.3 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Ichor Life Sciences, Inc Main Business Overview
11.1.5 Ichor Life Sciences, Inc Latest Developments
11.2 Creative BioMart
11.2.1 Creative BioMart Company Information
11.2.2 Creative BioMart Biolayer Interferometry (BLI) Product Offered
11.2.3 Creative BioMart Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Creative BioMart Main Business Overview
11.2.5 Creative BioMart Latest Developments
11.3 GenScript
11.3.1 GenScript Company Information
11.3.2 GenScript Biolayer Interferometry (BLI) Product Offered
11.3.3 GenScript Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GenScript Main Business Overview
11.3.5 GenScript Latest Developments
11.4 ROCKLAND IMMUNOCHEMICALS, INC
11.4.1 ROCKLAND IMMUNOCHEMICALS, INC Company Information
11.4.2 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Product Offered
11.4.3 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 ROCKLAND IMMUNOCHEMICALS, INC Main Business Overview
11.4.5 ROCKLAND IMMUNOCHEMICALS, INC Latest Developments
11.5 BPS Bioscience, Inc
11.5.1 BPS Bioscience, Inc Company Information
11.5.2 BPS Bioscience, Inc Biolayer Interferometry (BLI) Product Offered
11.5.3 BPS Bioscience, Inc Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BPS Bioscience, Inc Main Business Overview
11.5.5 BPS Bioscience, Inc Latest Developments
11.6 Creative Proteomics
11.6.1 Creative Proteomics Company Information
11.6.2 Creative Proteomics Biolayer Interferometry (BLI) Product Offered
11.6.3 Creative Proteomics Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Creative Proteomics Main Business Overview
11.6.5 Creative Proteomics Latest Developments
11.7 Creative Biostructure
11.7.1 Creative Biostructure Company Information
11.7.2 Creative Biostructure Biolayer Interferometry (BLI) Product Offered
11.7.3 Creative Biostructure Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Creative Biostructure Main Business Overview
11.7.5 Creative Biostructure Latest Developments
11.8 Profacgen
11.8.1 Profacgen Company Information
11.8.2 Profacgen Biolayer Interferometry (BLI) Product Offered
11.8.3 Profacgen Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Profacgen Main Business Overview
11.8.5 Profacgen Latest Developments
11.9 Creative Biolabs
11.9.1 Creative Biolabs Company Information
11.9.2 Creative Biolabs Biolayer Interferometry (BLI) Product Offered
11.9.3 Creative Biolabs Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Creative Biolabs Main Business Overview
11.9.5 Creative Biolabs Latest Developments
11.10 Biocult
11.10.1 Biocult Company Information
11.10.2 Biocult Biolayer Interferometry (BLI) Product Offered
11.10.3 Biocult Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Biocult Main Business Overview
11.10.5 Biocult Latest Developments
11.11 KMD Bioscience Co., Ltd
11.11.1 KMD Bioscience Co., Ltd Company Information
11.11.2 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Product Offered
11.11.3 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 KMD Bioscience Co., Ltd Main Business Overview
11.11.5 KMD Bioscience Co., Ltd Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂